The Molecular Diagnostics Market is projected to reach $46.69 billion by 2030, at a CAGR of 5.6% from 2023 to 2030. The molecular diagnostics market comprises advanced products and technologies used by medical professionals for patient management, from diagnosis to treatment, primarily focusing on areas such as infectious disease and cancer.
The growth of this market is driven by the rising global geriatric population, the increasing prevalence of communicable & non-communicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditures. However, unfavorable regulatory frameworks and the high costs of molecular diagnostic tests restrain the growth of this market.
The COVID-19 pandemic had a positive impact on the molecular diagnostics market in terms of revenue. However, the diagnosis of other disorders was reduced during the initial phase of the pandemic, and the COVID-19 testing capabilities were increased to limit the spread of infection. Some of the initiatives are mentioned below:
In February 2022, the Ministry of Health and Family Welfare (Government of India) issued new guidelines for international travelers, wherein all travelers arriving from abroad were required to submit negative COVID-19 RT-PCR reports.
Such initiatives positively impacted the demand for molecular diagnostics for COVID-19 during the pandemic.
Click here to: Get a Free Sample Copy of this report
The development of molecular diagnostic systems or assays requires significant capital investments. Thus, financial support in the form of funding is essential to develop and bring the technology into the market. Many molecular diagnostic devices that are in the developmental phase are being funded by various organizations. Below are some examples related to funding received by the companies that helped them focus on developing molecular diagnostics products.
In August 2022, Nanopath Inc. (U.S.) raised USD 10 million in Series A funding, co-led by Norwest Venture Partners and Medtech Convergence Fund. The funds will be used to develop a point-of-care diagnostics platform for women’s health screenings.
Key Findings of the Molecular diagnostics Market Study
In 2023, the Kits & Reagents Segment is Expected to Dominate the Molecular Diagnostics Market
Based on product & service, in 2023, the kits & reagents segment is expected to account for the largest share of the molecular diagnostics market. Recurrent use of assays & kits in the detection of various diseases through molecular diagnostics, rise in product approvals, and technological advancements in molecular techniques contribute to the large market share of this segment.
In 2023, the Laboratory Tests Segment is Expected to Dominate the Molecular Diagnostics Market
Based on test type, in 2023, the laboratory tests segment is expected to account for the largest share of the molecular diagnostics market. Lab tests are traditionally used in hospitals and diagnostic centers and are widely accepted. These factors contribute to the large market share of this segment.
In 2023, the Polymerase Chain Reaction (PCR) Segment is Expected to Dominate the Molecular Diagnostics Market
Based on technology, in 2023, the polymerase chain reaction (PCR) segment is expected to account for the largest share of the molecular diagnostics market. The specificity and sensitivity of the instrument and the technological developments in various diagnostic applications contribute to this segment's large market share.
In 2023, the Infectious Diseases Segment is Expected to Dominate Molecular Diagnostics Market
Based on application, in 2023, the infectious diseases segment is expected to account for the largest share of the molecular diagnostics market. Infectious diseases are transmissible or communicable illnesses that spread quickly in some areas and become epidemics. It is crucial to quickly diagnose initial infections and prevent further spread through in vitro diagnosis. The growing prevalence of infectious diseases, the rising funds for infectious disease diagnostic research activities, and the sudden emergence of a pandemic are the factors attributed to the large market share of this segment.
In 2023, the Hospitals & Clinics Segment is Expected to Dominate Molecular Diagnostics Market
Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the molecular diagnostics market. Factors attributing to this segment's share include increased hospitalizations due to various diseases, the rise in the geriatric population, and the high prevalence of healthcare-associated infections (HAIs).
Asia-Pacific: Fastest-growing Regional Market
Based on geography, Asia-Pacific is slated to record the fastest growth rate during the forecast period. The growth of this regional market is mainly driven by the rising prevalence of infectious & chronic diseases, the increasing number of hospitals and diagnostic laboratories, efforts to improve the accessibility of diagnostic services, and the growing demand for clinical testing.
Key Players
The key players profiled in the molecular diagnostics market study are F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (U.S.), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (BD) (U.S.), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), and Seegene, Inc. (South Korea).
Scope of the Report:
Molecular Diagnostics Market, by Product & Service
Molecular Diagnostics Market, by Test Type
Molecular Diagnostics Market, by Technology
Molecular Diagnostics Market, by Application
Molecular Diagnostics Market, by End User
Molecular Diagnostics Market, by Geography
Key questions answered in the report:
The molecular diagnostics market study covers the market sizes & forecasts for various molecular diagnostics products used in the healthcare sector. The report involves the value analysis of various segments and subsegments of the molecular diagnostics market at the regional and country levels.
The molecular diagnostics market is projected to reach $46.69 billion by 2030, at a CAGR of 5.6% during the forecast period.
Based on product & service, in 2023, the kits & reagents segment is expected to account for the largest share of the molecular diagnostics market. This segment is also projected to register the highest CAGR during the forecast period. The fast growth rate of this segment is driven by the need for kits for the growing prevalence of diseases and the growing awareness of early diagnosis among the people.
The diagnostic laboratories segment is slated to register the highest CAGR during the forecast period. The growth of this segment is driven by the expansion of diagnostic laboratories and the installation of advanced systems in laboratories.
The growth of this market is driven by the rising global geriatric population, the increasing prevalence of communicable & non-communicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditures.
In addition, the growing scope in emerging countries, increasing focus on companion diagnostics, and the rising popularity of direct-to-consumer (DTC) genetic testing are expected to provide significant opportunities for the growth of this market.
The key players operating in the molecular diagnostics market are F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (U.S.), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (BD) (U.S.), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), and Seegene, Inc. (South Korea).
Emerging economies from Asia-Pacific, such as China and India, are projected to offer significant growth opportunities for vendors operating in this market due to the growing awareness about infectious diseases, focus on technological advancements, increasing geriatric population, and increasing investment in the healthcare sector.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Rising Global Geriatric Population
4.2.2. Rising Prevalence of Communicable and Non-communicable Diseases
4.2.3. Technological Advancements in Molecular Diagnostics
4.2.4. Rising Healthcare Expenditure
4.3. Restraints
4.3.1. Unfavorable Regulatory Framework
4.3.2. High Costs of Molecular Diagnostic Tests
4.4. Opportunities
4.4.1. Growing Scope in Emerging Economies
4.4.2. Increasing Focus on Companion Diagnostics
4.4.3. Rising Popularity of Direct-to-Consumer (DTC) Genetic Testing
4.5. Challenges
4.5.1. Shortage of Skilled Professionals
4.6. Trends
4.6.1. Integration of Artificial Intelligence and Machine Learning
4.7. The Impact of COVID-19 on the Global Molecular Diagnostics Market
5. Pricing Analysis
6. Global Molecular Diagnostics Market: Regulatory Analysis
6.1. North America
6.1.1. U.S.
6.1.2. Canada
6.2. Europe
6.3. Asia-Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Global Molecular Diagnostics Market, by Product & Service
7.1. Introduction
7.2. Kits & Reagents
7.3. Instruments
7.4. Software & Services
8. Global Molecular Diagnostics Market, by Test Type
8.1. Introduction
8.2. Laboratory Tests
8.3. Point-of-Care (PoC) Tests
9. Global Molecular Diagnostics Market, by Technology
9.1. Introduction
9.2. Polymerase Chain Reaction (PCR)
9.3. In Situ Hybridization (ISH)
9.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
9.5. Microarrays
9.6. Mass Spectrometry
9.7. Sequencing
9.8. Other Technologies
10. Global Molecular Diagnostics Market, by Application
10.1. Introduction
10.2. Infectious Diseases
10.2.1. COVID-19
10.2.2. Hepatitis
10.2.3. HIV
10.2.4. Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG)
10.2.5. Human papillomavirus (HPV)
10.2.6. Tuberculosis
10.2.7. Influenza
10.2.8. Healthcare-associated Infections (HAIs)
10.2.9. Other Infectious Diseases
10.3. Oncology
10.3.1. Breast Cancer
10.3.2. Colorectal Cancer
10.3.3. Lung Cancer
10.3.4. Prostate Cancer
10.3.5. Lymphoma
10.3.6. Leukemia
10.3.7. Cervical Cancer
10.3.8. Other Cancer Types
10.4. Genetic Testing
10.5. Neurological Diseases
10.6. Cardiovascular Diseases
10.7. Other Applications
11. Global Molecular Diagnostics Market, by End User
11.1. Introduction
11.2. Hospitals & Clinics
11.3. Diagnostic Laboratories
11.4. Academic & Research Institutes
11.5. Other End Users
12. Molecular Diagnostics Market, by Geography
12.1. Introduction
12.2. North America
12.2.1. U.S.
12.2.2. Canada
12.3. Europe
12.3.1. Germany
12.3.2. France
12.3.3. U.K.
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Asia-Pacific
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. Australia
12.4.5. Rest of Asia-Pacific
12.5. Latin America
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Middle East & Africa
13. Competitive Landscape
13.1. Introduction
13.2. Key Growth Strategies
13.3. Competitive Benchmarking
13.3.1. Competitive Benchmarking, by Product
13.4. Market Share Analysis (2022)
14. Company Profiles
14.1. F. Hoffmann-La Roche Ltd
14.2. Hologic, Inc.
14.3. QIAGEN N.V.
14.4. Danaher Corporation
14.5. bioMérieux S.A.
14.6. Becton, Dickinson and Company (BD)
14.7. Siemens Healthineers AG
14.8. DiaSorin S.p.A.
14.9. Abbott Laboratories
14.10. Thermo Fisher Scientific Inc.
14.11. Agilent Technologies, Inc.
14.12. Illumina, Inc.
14.13. Seegene, Inc.
15. Appendix
15.1. Questionnaire
15.2. Available Customization
List of Tables
Table 1 Global Molecular Diagnostics Market: Impact Analysis of Market Drivers (2023–2030)
Table 2 Healthcare Expenditure as a Percentage of GDP, by Country (2014 VS. 2019)
Table 3 Global Molecular Diagnostics Market: Impact Analysis of Market Restraints (2023–2030)
Table 4 Requirements for CLIA-waived and Moderate & High-complexity PoC Molecular Diagnostic Tests
Table 5 Percentage of Urban Population in Emerging Countries (2015–2050)
Table 6 Recently Approved Companion Diagnostic Tests
Table 7 Recently Launched Molecular Diagnostic Tests for COVID-19
Table 8 Pricing of PCR Devices
Table 9 Pricing of Sequencers
Table 10 Comparison of Test Prices
Table 11 Some of the Emergency Use Authorizations (EUAs) Granted for Molecular Diagnostics During the COVID-19 Pandemic
Table 12 Medical Devices Regulatory Authorities in Europe, by Country
Table 13 Medical Devices Regulatory Authorities in the Rest of APAC countries
Table 14 IVD Regulatory Systems, by Country
Table 15 Global Molecular Diagnostics Market Size, by Product & Service, 2021–2030 (USD Million)
Table 16 Global Molecular Diagnostics Kits & Reagents Market Size, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Molecular Diagnostics Instruments Market Size, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Molecular Diagnostics Software & Services Market Size, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 20 Global Molecular Diagnostics for Laboratory Tests, by Country/Region, 2021–2030 (USD Million)
Table 21 Global Molecular Diagnostics for PoC Tests, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 23 Global Molecular Diagnostics for Polymerase Chain Reaction (PCR), by Country/Region, 2021–2030 (USD Million)
Table 24 Global Molecular Diagnostics for In Situ Hybridization (ISH), by Country/Region, 2021–2030 (USD Million)
Table 25 Global Molecular Diagnostics for Isothermal Nucleic Acid Amplification Technology (INAAT), by Country/Region, 2021–2030 (USD Million)
Table 26 Global Molecular Diagnostics for Microarrays, by Country/Region, 2021–2030 (USD Million)
Table 27 Global Molecular Diagnostics for Mass Spectrometry, by Country/Region, 2021–2030 (USD Million)
Table 28 Global Molecular Diagnostics for Sequencing, by Country/Region, 2021–2030 (USD Million)
Table 29 Global Other Technologies Market Size, by Country/Region, 2021–2030 (USD Million)
Table 30 Global Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 31 Global Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 32 Global Molecular Diagnostics Market Size for Infectious Diseases Market Size, by Country/Region, 2021–2030 (USD Million)
Table 33 Recently Launched Molecular Diagnostic Tests for COVID-19 Detection
Table 34 Global Infectious Disease Molecular Diagnostics Market Size for COVID-19 Testing, by Country/Region, 2021–2030 (USD Million)
Table 35 Global Infectious Disease Molecular Diagnostics Market Size for Hepatitis Testing, by Country/Region, 2021–2030 (USD Million)
Table 36 HIV Prevalence by Region (2020)
Table 37 Global Infectious Disease Molecular Diagnostics Market Size for HIV Testing, by Country/Region, 2021–2030 (USD Million)
Table 38 Global Infectious Disease Molecular Diagnostics Market Size for CT/NG Testing, by Country/Region, 2021–2030 (USD Million)
Table 39 Global Infectious Disease Molecular Diagnostics Market Size for Human papillomavirus (HPV) Testing, by Country/Region, 2021–2030 (USD Million)
Table 40 Global Infectious Disease Molecular Diagnostics Market Size for Tuberculosis Testing, by Country/Region, 2021–2030 (USD Million)
Table 41 Global Infectious Disease Molecular Diagnostics Market Size for Influenza Testing, by Country/Region, 2021–2030 (USD Million)
Table 42 Global Infectious Disease Molecular Diagnostics Market Size for Healthcare-associated Infections (HAIs) Testing, by Country/Region, 2021–2030 (USD Million)
Table 43 Global Molecular Diagnostics Market Size for Other Infectious Diseases Testing, by Country/Region, 2021–2030 (USD Million)
Table 44 Estimated Number of New Cancer Cases (2020–2035)
Table 45 Global Oncology Molecular Diagnostics Market Size, by Type, 2021–2030 (USD Million)
Table 46 Global Oncology Molecular Diagnostics Market Size, by Country/Region, 2021–2030 (USD Million)
Table 47 Number of New Breast Cancer Cases Globally (2020–2035)
Table 48 Global Oncology Molecular Diagnostics Market Size for Breast Cancer Testing, by Country/Region, 2021–2030 (USD Million)
Table 49 Global Oncology Molecular Diagnostics Market Size for Colorectal Cancer Testing, by Country/Region, 2021–2030 (USD Million)
Table 50 Global Oncology Molecular Diagnostics Market Size for Lung Cancer Testing, by Country/Region, 2021–2030 (USD Million)
Table 51 Number of New Prostate Cancer Cases (2020–2035)
Table 52 Global Oncology Molecular Diagnostics Market Size for Prostate Cancer Testing, by Country/Region, 2021–2030 (USD Million)
Table 53 Number of New Non-Hodgkin lymphoma Cancer Cases (2020–2035)
Table 54 Global Oncology Molecular Diagnostics Market Size for Lymphoma Testing, by Country/Region, 2021–2030 (USD Million)
Table 55 Estimated Number of New Leukemia Cancer Cases (2020–2035)
Table 56 Global Oncology Molecular Diagnostics Market Size for Leukemia Testing, by Country/Region, 2021–2030 (USD Million)
Table 57 Global Oncology Molecular Diagnostics Market Size for Cervical Cancer Testing, by Country/Region, 2021–2030 (USD Million)
Table 58 Number of New Cancer Cases (2020-2035)
Table 59 Global Oncology Molecular Diagnostics Market Size for Other Cancer Types Testing, by Country/Region, 2021–2030 (USD Million)
Table 60 Global Genetic Testing Molecular Diagnostics Market Size, by Country/Region, 2021–2030 (USD Million)
Table 61 Global Neurological Diseases Molecular Diagnostics Market Size, by Country/Region, 2021–2030 (USD Million)
Table 62 Global Cardiovascular Diseases Molecular Diagnostics Market Size, by Country/Region, 2021–2030 (USD Million)
Table 63 Global Other Applications Molecular Diagnostics Market Size, by Country/Region, 2021–2030 (USD Million)
Table 64 Global Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 65 Global Molecular Diagnostics Market Size for Hospitals & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 66 Global Molecular Diagnostics Market Size for Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 67 Global Molecular Diagnostics Market Size for Academic & Research Institutes, by Country/Region, 2021–2030 (USD Million)
Table 68 Global Molecular Diagnostics Market Size for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 69 Global Molecular Diagnostics Market Size, by Country/Region, 2021–2030 (USD Million)
Table 70 Estimated Cancer Cases in North America: 2020–2030
Table 71 North America: Molecular Diagnostics Market Size, by Country, 2021–2030 (USD Million)
Table 72 North America: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 73 North America: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 74 North America: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 75 North America: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 76 North America: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 77 North America: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 78 North America: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 79 Recently Approved Molecular Diagnostic Products in the U.S.
Table 80 U.S.: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 81 U.S.: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 82 U.S.: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 83 U.S.: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 84 U.S.: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 85 U.S.: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 86 U.S.: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 87 Canada: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 88 Canada: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 89 Canada: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 90 Canada: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 91 Canada: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 92 Canada: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 93 Canada: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 94 Europe: Molecular Diagnostics Market Size, by Country/Region, 2021–2030 (USD Million)
Table 95 Europe: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 96 Europe: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 97 Europe: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 98 Europe: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 99 Europe: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 100 Europe: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 101 Europe: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 102 Germany: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 103 Germany: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 104 Germany: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 105 Germany: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 106 Germany: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 107 Germany: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 108 Germany: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 109 France: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 110 France: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 111 France: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 112 France: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 113 France: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 114 France: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 115 France: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 116 U.K.: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 117 U.K.: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 118 U.K.: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 119 U.K.: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 120 U.K.: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 121 U.K.: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 122 U.K.: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 123 Italy: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 124 Italy: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 125 Italy: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 126 Italy: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 127 Italy: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 128 Italy: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 129 Italy: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 130 Spain: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 131 Spain: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 132 Spain: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 133 Spain: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 134 Spain: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 135 Spain: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 136 Spain: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 137 Estimated Number of New Cancer Cases (2030)
Table 138 Rest of Europe: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 139 Rest of Europe: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 140 Rest of Europe: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 141 Rest of Europe: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 142 Rest of Europe: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 143 Rest of Europe: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 144 Rest of Europe: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 145 Asia-Pacific: Molecular Diagnostics Market Size, by Country/Region, 2021–2030 (USD Million)
Table 146 Asia-Pacific: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 147 Asia-Pacific: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 148 Asia-Pacific: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 149 Asia-Pacific: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 150 Asia-Pacific: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 151 Asia-Pacific: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 152 Asia-Pacific: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 153 China: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 154 China: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 155 China: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 156 China: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 157 China: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 158 China: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 159 China: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 160 Japan: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 161 Japan: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 162 Japan: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 163 Japan: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 164 Japan: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 165 Japan: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 166 Japan: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 167 India: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 168 India: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 169 India: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 170 India: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 171 India: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 172 India: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 173 India: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 174 Australia: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 175 Australia: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 176 Australia: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 177 Australia: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 178 Australia: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 179 Australia: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 180 Australia: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 181 Estimated Number of New Cancer Cases in the Rest of Asia-Pacific, by Country (2020–2030)
Table 182 Rest of Asia-Pacific: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 183 Rest of Asia-Pacific: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 184 Rest of Asia-Pacific: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 185 Rest of Asia-Pacific: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 186 Rest of Asia-Pacific: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 187 Rest of Asia-Pacific: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 188 Rest of Asia-Pacific: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 189 Latin America: Molecular Diagnostics Market Size, by Country/Region, 2021–2030 (USD Million)
Table 190 Latin America: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 191 Latin America: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 192 Latin America: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 193 Latin America: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 194 Latin America: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 195 Latin America: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 196 Latin America: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 197 Brazil: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 198 Brazil: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 199 Brazil: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 200 Brazil: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 201 Brazil: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 202 Brazil: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 203 Brazil: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 204 Mexico: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 205 Mexico: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 206 Mexico: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 207 Mexico: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 208 Mexico: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 209 Mexico: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 210 Mexico: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 211 Rest of Latin America: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 212 Rest of Latin America: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 213 Rest of Latin America: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 214 Rest of Latin America: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 215 Rest of Latin America: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 216 Rest of Latin America: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 217 Rest of Latin America: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 218 Middle East & Africa: Molecular Diagnostics Market Size, by Product, 2021–2030 (USD Million)
Table 219 Middle East & Africa: Molecular Diagnostics Market Size, by Test Type, 2021–2030 (USD Million)
Table 220 Middle East & Africa: Molecular Diagnostics Market Size, by Technology, 2021–2030 (USD Million)
Table 221 Middle East & Africa: Molecular Diagnostics Market Size, by Application, 2021–2030 (USD Million)
Table 222 Middle East & Africa: Molecular Diagnostics Market Size for Infectious Diseases, by Type, 2021–2030 (USD Million)
Table 223 Middle East & Africa: Molecular Diagnostics Market Size for Oncology, by Type, 2021–2030 (USD Million)
Table 224 Middle East & Africa: Molecular Diagnostics Market Size, by End User, 2021–2030 (USD Million)
Table 225 Recent Developments, by Company, 2020—2022
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Molecular Diagnostic Market Size, by Product & Service, 2022 VS. 2029 (USD Million)
Figure 8 Global Molecular Diagnostic Market Size, by Test Type, 2022 VS. 2029 (USD Million)
Figure 9 Global Molecular Diagnostic Market Size, by Technology, 2022 VS. 2029 (USD Million)
Figure 10 Global Molecular Diagnostic Market Size, by Application, 2022 VS. 2029 (USD Million)
Figure 11 Global Molecular Diagnostic Market Size, by End User, 2022 VS. 2029 (USD Million)
Figure 12 Molecular Diagnostic Market, by Geography
Figure 13 Market Dynamics
Figure 14 Population Aged 65 Years or Over, by Region, 2020 VS. 2030 (In Million)
Figure 15 Global Molecular Diagnostics Market Size, by Product & Service, 2023–2030 (USD Million)
Figure 16 Global Molecular Diagnostics Market Size, by Test Type, 2023–2030 (USD Million)
Figure 17 Global Molecular Diagnostics Market Size, by Technology, 2023–2030 (USD Million)
Figure 18 Global Molecular Diagnostics Market Size, by Application, 2023–2030 (USD Million)
Figure 19 New Cancer Cases, by Cancer Type, 2020
Figure 20 Global Molecular Diagnostics Market Size, by End User, 2023–2030 (USD Million)
Figure 21 U.S.: Home Healthcare Spending, 2017–2026 (USD Billion)
Figure 22 Global Molecular Diagnostics Market Size, by Country/Region, 2023–2030 (USD Million)
Figure 23 North America: Molecular Diagnostics Market Snapshot
Figure 24 Canada: Number of Inpatient Admissions in Acute-Care Hospitals, 2016–2020 (Per 1,00,000 Population)
Figure 25 Europe: Molecular Diagnostics Market Snapshot
Figure 26 France: Population Aged 65 and Above (2016–2021)
Figure 27 U.K.: Number of People Diagnosed with Sexually Transmitted Infections, 2018–2020 (In Thousands)
Figure 28 Number of HIV Tests Performed in Catalonia, Spain (2014–2020)
Figure 29 Health Expenditure (2015–2020)
Figure 30 Asia-Pacific: Molecular Diagnostics Market Snapshot
Figure 31 Japan: Population Over 65 Years of Age (2017–2021)
Figure 32 Latin America: Molecular Diagnostics Market Snapshot
Figure 33 Latin America: Estimated Number of New Cancer Cases (2020–2030)
Figure 34 Key Growth Strategies Adopted by Leading Players, 2020—2022
Figure 35 Molecular Diagnostics Market: Competitive Benchmarking
Figure 36 Market Share Analysis: Molecular Diagnostics Industry (2022)
Figure 37 F. Hoffmann-La Roche Ltd: Financial Overview (2021)
Figure 38 Hologic, Inc.: Financial Overview (2021)
Figure 39 QIAGEN N.V.: Financial Overview (2021)
Figure 40 Danaher Corporation: Financial Overview (2021)
Figure 41 BioMérieux S.A.: Financial Overview (2021)
Figure 42 Becton, Dickinson and Company: Financial Overview (2021)
Figure 43 Siemens Healthineers AG: Financial Overview (2021)
Figure 44 DiaSorin S.p.A.: Financial Overview (2021)
Figure 45 Abbott Laboratories: Financial Overview (2021)
Figure 46 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 47 Agilent Technologies, Inc.: Financial Overview (2021)
Figure 48 Illumina, Inc.: Financial Overview (2021)
Figure 49 Seegene, Inc.: Financial Overview (2021)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Nov-2023
Published Date: Nov-2023
Published Date: Sep-2023
